Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Xencor

Critical Insights From Xencor Analyst Ratings: What You Need To Know

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Xencor (NASDAQ:XNCR) in the last three months.

Benzinga · Dec 2, 2024

2 Beaten-Down Growth Stocks With 90% or More Upside Potential in 2024

While these stocks have taken a beating this year, Wall Street believes they have major rebound potential in 2024.

Barchart · Dec 7, 2023

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022

Upgrades

Benzinga · Oct 13, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

Benzinga · Sep 21, 2022

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Aug 2, 2022

Xencor's Earnings Outlook

Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report an earnings per share (EPS) of $-0.60.

Benzinga · May 4, 2022

Xencor: Q4 Earnings Insights

Xencor (NASDAQ:XNCR) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Xencor beat estimated earnings by 1310.0%, reporting an EPS of $1.21 versus an estimate of $-0.1.

Benzinga · Feb 23, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Cancer

25,506 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.